Cargando…
A Key to T1D Prevention: Screening and Monitoring Relatives as Part of Clinical Care
The 2019 report of a randomized, placebo-controlled clinical trial demonstrating that immune therapy can delay the onset of clinical type 1 diabetes (T1D) in antibody-positive relatives by a median of 2 years stands out as a landmark in the decades-long effort to prevent T1D. With this important ste...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173797/ https://www.ncbi.nlm.nih.gov/pubmed/33931405 http://dx.doi.org/10.2337/db20-1112 |